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induced Foxp3+ T cells colonizing 
Tolerated allografts exhibit the 
hypomethylation Pattern Typical of 
Mature regulatory T cells
Robert Hilbrands , Ye Chen , Adrian R. Kendal , Elizabeth Adams , Stephen P. Cobbold , 
Herman Waldmann* † and Duncan Howie†
Therapeutic Immunology Group, Sir William Dunn School of Pathology, University of Oxford, Oxford, UK
Regulatory T cells expressing the transcription factor Foxp3 require acquisition of a 
specific hypomethylation pattern to ensure optimal functional commitment, limited lin-
eage plasticity, and long-term maintenance of tolerance. A better understanding of the 
molecular mechanisms involved in the generation of these epigenetic changes in vivo 
will contribute to the clinical exploitation of Foxp3+ Treg. Here, we show that both in vitro 
and in vivo generated antigen-specific Foxp3+ Treg can acquire Treg-specific epigenetic 
characteristics and prevent skin graft rejection in an animal model.
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inTrODUcTiOn
Regulatory T cells expressing the transcription factor Foxp3 (Foxp3+ Treg) develop in both the thymus 
(tTreg) and the periphery (pTreg). Together, they form a pool of naturally arising Treg (nTreg) that 
form an essential part of the immune system ensuring adequate immune homeostasis via control of 
inflammation and diverse immune responses (1–4). Induction, or restoration, of immune tolerance 
through harnessing of Foxp3+ Treg has been achieved in many animal models. However, translation 
toward the clinic has been limited, likely due to a lack of understanding of the molecular mechanisms 
required for Treg generation and long-term maintenance. Recently, Ohkura et al. showed that two 
independent processes are required for the development of stable Foxp3+ Treg. These are the induc-
tion of Foxp3 expression, and the installation of a Treg-specific hypomethylation pattern to establish 
lineage commitment (5). Only those T-cells demonstrating both processes are committed to the 
Treg cell lineage and to stable function. Better understanding of how these processes occur would 
enable generation, both in vitro and in vivo, of Foxp3+ Treg that are functionally stable, an essential 
requirement for their therapeutic application (6, 7).
In vitro generation of Foxp3+ Treg (iTreg) requires TCR stimulation of naive CD4+ T cells in the 
presence of TGF-β, but is in itself insufficient to establish those Treg-specific epigenetic changes. As 
a consequence, iTreg appear unstable with rapid loss of Foxp3 expression when transferred in vivo, 
accompanied by the production of diverse proinflammatory cytokines. This is in sharp contrast to the 
apparent stability of Foxp3 expression of naturally occurring mature Treg (5, 8, 9). Inhibition of DNA 
methylation within iTreg using azacytidine stabilizes Foxp3 expression and enhances demethylation 
of the Treg-specific demethylated region (TSDR) (10). Together, these data have demonstrated a 
significant contribution of the Treg-specific hypomethylation pattern to lineage stability. Although 
administration of IL2/anti-IL2 complexes helps to stabilize Foxp3 expression in iTreg in vivo with 
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increased demethylation of the TSDR, it remains incompletely 
understood how iTreg can be stabilized and acquire epigenetic 
maturation in vivo (11).
Harnessing TGF-β-dependent pTreg within the body to achieve 
antigen-specific tolerance is now an attractive therapeutic goal. 
We have previously demonstrated that TCR-transgenic RAG−/− 
mice, lacking Treg, can still be tolerized to skin grafts carrying the 
nominal antigen. This was achieved through coreceptor blockade 
with anti-CD4 antibodies (12, 13). Transplantation tolerance in 
this model absolutely depended on the induction of Foxp3+ pTreg 
and their sustained presence (14). The induction of pTreg in this 
system also depends on the presence of active TGF-β (13).
Here, we use this TCR-transgenic mouse model to determine 
the requirements for both sustained Foxp3 expression and 
Treg-specific hypomethylation in the setting of acquired trans-
plantation tolerance. We investigated these requirements both for 
in vitro generated antigen-specific iTreg after adoptive transfer in 
lymphopenic hosts bearing skin grafts and for in vivo generated 
antigen-specific pTreg following anti-CD4 blockade. Together, 
our data demonstrate that renewed antigen stimulation by the 
tolerated tissue enhances the number of T-cells that demonstrate 
a stable Treg-specific hypomethylation pattern.
MaTerials anD MeThODs
experimental Mice
B6.Foxp3hCD2 knock-in, RAG1−/− Marilyn.Foxp3hCD2 knock-in, 
B6.RAG1−/−, and CBA.RAG1−/− were bred and maintained under 
specific pathogen-free conditions in the animal facility of the 
Sir William Dunn School of Pathology. B6.Foxp3hCD2 knock-in 
and RAG1−/− Marilyn.Foxp3hCD2 knock-in were generated, as 
described previously (14).
Transplantation and adoptive cell Transfer
All animal procedures were performed in accordance with the 
Home Office Animals (Scientific Procedures) Act of 1986 under 
project license numbers PPL 30/2549 and PPL 30/3060. Local 
ethical committee approval was also obtained. Skin grafting was 
conducted with full thickness skin tail (1 cm × 1 cm) on the lateral 
flank, as previously described (15). Grafts were observed daily 
after cast was removed at day 8 and considered rejected when no 
viable skin was present. Adoptive transfer of sorted or unsorted 
cells was achieved by tail vein injection using an appropriate 
volume of washed cell suspension in sterile 1× PBS. In some 
experiments, CBA.RAG−/− mice were used as donors to C57.Bl/6 
recipients, so that the color difference left no doubt about rejec-
tion via the indirect pathway.
Bone Marrow Dendritic cell Preparation
C57Bl/6 bone marrow was sieved through a 70-μm nylon mesh 
in R10 medium (RPMI 1640, 10% FCS, 2 mM l-glutamine, 50 U/
ml penicillin, 50  μg/ml streptomycin, 5 ×  10−5M, and 50  μM 
2-mercapto-ethanol), and cells plated at 7.5 ×  106/10  cm plate 
(Corning Inc., Corning, NY, USA), supplemented with ~25 ng/ml 
murine recombinant GM-CSF, supplied as culture supernatant. 
Medium was replaced on days 3 and 6. Bone marrow dendritic 
cells (BMDCs) were replated on day 6 and harvested on day 7 by 
gentle pipetting.
In Vitro Treg generation
RAG1−/− Marilyn.Foxp3hCD2 spleen cells were harvested and 
prepared, including red blood cell lysis, under sterile conditions. 
About 5 ×  105 RAG1−/− Marilyn.Foxp3hCD2 cells were cultured 
at 37°C and 6% of CO2 in 2  ml of R10 medium [RPMI 1640 
medium (Lonza) +  10% vol/vol FCS (Invitrogen) +  50  μg/ml 
penicillin  +  streptomycin (Invitrogen)  +  2  mM l-glutamine 
(Invitrogen)  +  50  μM 2-mercapto-ethanol], 2  ng/ml TGF-β, 
1 × 105 B6.WT BMDCs, and 100 nM of male H-Y peptide (Dby 
H-2Ab; NAGFNSNRANSSRSS). Cultures were harvested at day 7.
In Vivo pTreg generation
Female RAG1−/− Marilyn.Foxp3hCD2 mice were grafted with 
male B6.RAG1−/− skin and treated with three doses of 1  mg 
non-depleting anti-CD4 (YTS 177.9) over 7 days. Mice were 
sacrificed at week 10. Spleen, non-draining and draining 
lymph nodes were harvested separately and prepared for flow 
cytometry. Subsequently, samples were pooled to obtain suf-
ficient cell numbers for MoFlo sorting and DNA methylation 
analysis.
Flow cytometry staining and cell isolation
Spleen, draining and non-draining lymph nodes were labeled 
directly with fluorescently conjugated antibodies. Four-color 
analysis was performed using a FACS Calibur (BD) with dual 
laser (488 and 633 nm) excitation. The analysis gate was set on 
the forward and side scatters to eliminate cell debris and dead 
cells. For cell isolation, cells were purified from pooled spleens 
and lymph nodes using a 70-μm cell strainer. Cells were stained 
using mouse monoclonal anti-hCD2 PE conjugated antibodies 
RPA-2.10 (BD Pharmingen), rat anti-CD4 APC conjugated 
antibodies RMA4–5 (BD Pharmingen), and hamster anti-TCR 
PerCP conjugated H57-597 (BD Pharmingen) conjugated 
antibodies. Single stain samples were also prepared for MoFlo 
calibration before cell sorting. Cells were MoFlo cell sorted as 
per manufacturer’s guidelines.
Dna Methylation analysis
Bisulfite converted DNA was obtained from MoFlo sorted cells 
using Epitect Fast LyseAll Bisulfite conversion kit (Qiagen). 
Converted DNA was amplified by PCR and subcloned with 
TOPO®TA cloning kit (Invitrogen). PCR primers for TSDR 
were designed using MethPrimer software, Forward primer: 
TTTTGGGTTTTTTTGGTATTTAAGA, and Reverse primer: 
AACCAACCAACTTCCTACACTATCTAT. Primers for Tnfrsf18 
exon 5, Ctla4 exon 2, and Eos (Ikzf4) intron 1b were used as 
described by Ohkura et al. Clones (n = 10–30) were incubated 
overnight in 2 ml LB medium with ampicillin and screened for 
the presence of insert using PCR. When the insert was present, 
plasmids were extracted using Miniprep Kits (Qiagen) and 
sequenced. Visualization and quality control for DNA meth-
ylation of sequenced clones were performed with BiQ Analyzer 
[(16), p. 4067–8].
FigUre 1 | nTreg are characterized by a specific hypomethylation pattern. (a) Naturally occurring TCR+CD4+Foxp3+ Treg (nTreg) and TCR+CD4+Foxp3− 
conventional T cells (Tconv) were isolated from spleen and lymph nodes of B6.Foxp3hCD2 knock-in mice. (B) CpG methylation status of established Treg-specific 
gene regions (nTreg-Me). TSDR, Treg-specific demethylated region. Data representative of five separate experiments.
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resUlTs
iTreg can acquire epigenetic Maturity 
In Vivo
Based on a genome-wide DNA methylation analysis, Ohkura 
et al. (5) established that the identity of naturally occurring Treg 
(nTreg, which comprise both tTreg and pTreg) is characterized 
by a Treg-specific hypomethylation pattern on four genomic 
regions located in genes encoding for Treg-specific proteins. 
These include the Foxp3 TSDR (TSDR–FOXP3), Tnfrsf18 exon 5 
(GITR), Ctla4 exon 2 (CTLA-4), and Eos (Ikzf4) intron 1b (EOS). 
Together, they are defined as “nTreg-Me” (5).
First, we studied this Treg-specific hypomethylation pattern 
in nTreg obtained from B6.Foxp3hCD2 reporter mice (14). These 
mice have an identical genetic background to wild-type C57BL/6 
(B6) mice and allow reliable isolation of live Foxp3− and Foxp3+ 
populations for cell sorting and adoptive transfer studies (14). We 
isolated conventional CD4+ T cells (TCR+CD4+hCD2[Foxp3]−) 
and nTreg (TCR+CD4+hCD2[Foxp3]+) from spleen and lymph 
nodes (Figure 1A). Bisulfite sequencing of selected DNA regions 
demonstrated hypomethylation at nTreg-Me loci, whereas these 
regions remained completely methylated in conventional (Foxp3−) 
CD4+ T cells (Figure 1B). This confirms the earlier findings of 
Ohkura et al. (5) and further illustrates that nTreg derived from 
the B6.Foxp3hCD2 reporter mice are an epigenetically homogenous 
population of Foxp3+ Treg. In female mice, the methylation 
status of the TSDR was around the expected 50% based on the 
non-functional Foxp3 gene on the (inactivated) X-chromosome 
(Figure  S1 in Supplementary Material). This “quantitation” 
allowed us to set the baseline expected for any demethylated 
Foxp3+ T-cells developing in female TCR-transgenic mice.
Next, we investigated the stability of Foxp3 expression and 
epigenetic characteristics of antigen-specific iTreg derived from 
naive CD4+ T cells cultured with antigen and TGF-β in vitro. We 
made use of female TCR-transgenic C57BL/6 Rag−/− Marilyn.
Foxp3hCD2 mice (14) that exhibit only CD4+ lymphocytes with a 
single TCR specificity recognizing the male Dby peptide. These 
mice have no nTreg in their thymus or periphery. They reject 
skin grafts bearing the male antigen expressed on both a B6 
Rag1−/− and CBA Rag1−/− background (the latter through indirect 
presentation only and used for easy scoring of rejection), but do 
not reject grafts from female donors (Figure 2A). As few as 2500 
Marilyn CD4+ naive T cells adoptively transferred into a female 
B6 Rag1−/− recipient gives a prompt rejection of all male skin 
grafts by day 10.
Marilyn.Foxp3hCD2 T-cells provide a useful source of antigen-
specific iTreg developing after an in vitro stimulation with DCs 
and antigen in the presence of TGF-β (Figure 2B). Both unsorted 
TGF-β conditioned T-cells and hCD2 (Foxp3)+ sorted TGF-β 
conditioned cells were unable to reject male skin grafts when 
transferred into lymphopenic B6 Rag1−/− mice (Figure 2C). By 
contrast, antibody ablation of the hCD2 (Foxp3)+ iTreg cells 
contained within unsorted TGF-β conditioned cultures enabled 
those remaining cells to reject male grafts rapidly (Figure 2C). 
Furthermore, sorted hCD2(Foxp3)− TGF-β-conditioned 
non-Treg cells also rejected rapidly, demonstrating that in vitro-
induced hCD2(Foxp3)+ iTreg cells were competent to suppress 
all potential pathogenic Foxp3− T cells within the cell mix. To 
confirm this, we challenged B6 Rag1−/− mice that previously 
received 106 TGF-β conditioned cells, either unsorted or sorted, 
with a second CBA Rag1−/− male skin graft and 105 CD4+ naive 
Marilyn T cells. Mice previously treated with in  vitro-induced 
Foxp3+ iTreg (either sorted or unsorted) maintained long-term 
graft survival, whereas those receiving hCD2 (Foxp3)− cells 
rejected their grafts rapidly (Figure  2D). Together, these data 
demonstrate that Dby specific in vitro-Foxp3+ iTreg fail to reject 
male skin grafts and are functional suppressors in vivo.
It is well recognized that in vitro-induced Foxp3+ T cells are 
an unstable population, with the majority of cells losing Foxp3 
expression in vivo and reacquiring the capacity to generate pro-
inflammatory cytokines (8). The determinants of in vivo stability 
of iTreg are less well understood. Our observation of long-term 
FigUre 2 | antigen-specific TgF-β conditioned iTreg prevent graft rejection. (a) B6.RAG1−/− Marilyn.Foxp3hCD2 knock-in mice reject skin grafts from male 
B6.RAG1−/− and CBA.RAG1−/− mice. Female CBA.RAG1−/− lack male antigen and are accepted. Statistical analysis Log-Rank test; *p < 0.05, ns, not significant.  
(B) Generation of Dby-specific in vitro-induced Foxp3+ Treg (iTreg) from splenocytes derived from female B6.RAG1−/− Marilyn.Foxp3hCD2 mice in the presence or 
absence of additional TGF-β (2 ng/ml), Dby peptide, and female B6 wild-type derived bone marrow dendritic cells. Data representative of at least three experiments. 
(c) 1 × 106 unsorted and sorted TGF-β conditioned cells (iTreg) were adoptively transferred to lymphopenic B6.RAG1−/− mice with or without hCD2 ablation 
treatment. Mice received skin grafts from male CBA.RAG1−/− mice. Statistical analysis Log-Rank test; *p < 0.01. (D) Mice received an initial male CBA RAG1−/− skin 
graft and treatment as indicated. Thirty days following the first skin graft, 105 Marilyn CD4 T cells were injected i.v. and a fresh male CBA RAG−/− skin graft was 
transplanted on the contralateral flank of recipients. Statistical analysis Log-Rank test; *p < 0.01. All data representative of three separate experiments.
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graft survival and functional suppression in  vivo suggests that 
Foxp3 expression in iTreg must be stabilized in vivo, at least in 
some T cells.
We investigated the stability of Foxp3 expression in vivo and 
any association with epigenetic changes, as previously observed 
in nTreg (5). For this purpose, we sorted hCD2+ iTreg with >95% 
purity. When these iTreg were transferred into female B6 Rag1−/−, 
grafted with a male graft, then 4 weeks later, 3.8 ± 0.9% of total 
live cells in draining lymph nodes maintained Foxp3 expression 
(Figure 3A). When no antigen was provided, as in the case of 
a female skin graft, very few (0.6 ±  0.22% of total live cells) 
still expressed Foxp3 (p = 0.029 versus male graft). Similar but 
non-significant differences were observed in the spleen and non-
draining lymph nodes (Figure 3A). This difference was reflected 
in total TCR+ CD4+ numbers as a percentage of total live cells. 
However, the relative percentage of Foxp3+ cells within the CD4+ 
T cell pool did not significantly vary between those mice receiving 
male or female grafts. Together, these data suggest an important 
role for antigen in enabling the persistence, expansion, and accu-
mulation of CD4 T cells including Foxp3-expressing cells. This 
is in line with previous observations that the persistent presence 
of antigen is required to maintain long-term Treg-dependent 
transplantation tolerance (14, 17).
The instability of iTreg after short-term in  vitro culture has 
been attributed to the absence of a required epigenetic signature 
(5, 8). However, our data suggest that Foxp3 expression can be 
maintained in some transferred iTreg in  vivo for an extended 
period of time and clearly renders some cells able to provide 
sustained suppression. We investigated the epigenetic “nTreg-
Me” signatures in Foxp3+ cells isolated from mice which had 
received iTreg and had not rejected their male grafts. The Foxp3+ 
cell numbers in mice given female skin grafts were simply too few 
for any epigenetic analysis. Before infusion of the iTreg, there was 
little evidence of hypomethylation of “nTreg-Me” loci, a finding 
in line with observations by others (Figure 3B). However, one 
clone did show full hypomethylation of the TSDR locus sug-
gesting that a small minority of iTreg can acquire an epigenetic 
hypomethylation pattern even after just 7  days in  vitro culture 
(Figure  S2 in Supplementary Material). When we assessed the 
“nTreg-Me” in Foxp3+ cells 4 weeks after transfer in mice holding 
a male skin graft, we observed a hypomethylation pattern that 
was comparable to that found in wild-type nTreg (Figure  3B). 
Since cells were derived from female mice, the minimal TSDR 
methylation expected was around 50%, which was what we actu-
ally observed. Collectively, these data demonstrate that some of 
the T cells-induced in  vitro to express Foxp3 can be stabilized 
in  vivo in circumstances where they are re-exposed to antigen 
and can acquire epigenetic maturation comparable to wild-type 
nTreg. The fact that iTreg failed to reject skin grafts and demon-
strate functional suppression in vivo, even after a challenge with 
naive CD4+ T cells, strongly suggests a sustained commitment to 
the Treg lineage of at least some of these cells.
FigUre 3 | TgF-β conditioned iTreg acquire Treg-specific hypomethylation status in vivo. (a) Female B6.RAG1−/− Marilyn.Foxp3hCD2 mice received 106 
MoFlo sorted Dby-specific iTreg and either a male or female skin graft. Mice were sacrificed at week 4 and spleen, lymph nodes (LN), and draining lymph nodes 
(DLN) analyzed for the presence of Foxp3+ cells. Data are presented as TCR+ CD4+ cells as a percentage of total live cells, Foxp3+ cells as a percentage of TCR+ 
CD4+ cells and Foxp3+ cells as a percentage of total live cells. “F MG” indicates female recipients with a male graft, “F FG” indicates female recipients with a female 
graft. Statistical analysis, Mann–Whitney U test. (B) Treg-specific hypomethylation pattern was assessed in Foxp3+ iTreg before transfer and in Foxp3+ cells isolated 
from mice bearing a male skin graft. Results from nTreg are shown as control for adequate comparison. Data representative of three separate experiments.
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Treg-specific hypomethylation has been reported to be 
 incomplete in recent thymic emigrants with further epigenetic 
maturation developing in the periphery (5, 18). The subsequent 
signals driving progressive epigenetic maturation remain incom-
pletely understood. The development of the epigenetic hallmark 
of tTreg requires TCR stimulation but is independent of Foxp3 
expression (5). Continued TCR signaling is important for main-
tenance of Treg suppressor function, but not for Foxp3 expres-
sion in already established nTreg (19). Furthermore, Ohkura 
et al. demonstrated (5) that sustained TCR stimulation in vitro 
could also induce partial Treg-specific hypomethylation in some 
nTreg-Me regions, but not the TSDR in naive CD4+ T cells, 
suggesting that duration rather than intensity of TCR signaling 
is critical to epigenetic maturation. Our data are not inconsist-
ent with these findings and possibly extend them to iTreg, by 
demonstrating that more iTreg accumulate in circumstances of 
renewed antigen exposure than without antigen, and that these 
show the characteristic hypomethylation pattern of mature Treg. 
As there were too few Foxp3+ T cells available from mice that had 
received female skin grafts, we were not able to conclude a role 
for antigen in maintaining the hallmark epigenetic pattern of the 
iTreg, which had remained.
Treg-specific hypomethylation can Be 
induced by coreceptor Blockade of naive 
T cells In Vivo
Adoptive transfer of iTreg has proven effective in enabling trans-
plantation tolerance in rodents (20), but induction of pTreg from 
within the graft recipient might be more practical for human appli-
cation. We asked whether pTreg demonstrating an “nTreg-Me” 
signature could be induced by coreceptor blockade in vivo from 
conventional T cells. To this end, we treated female Marilyn mice 
receiving a male skin graft with coreceptor blockade (anti-CD4), 
a treatment that results in long-term graft acceptance via the 
emergence of pTreg (14). In this model, the continuous presence 
of pTreg is indispensable for long-term graft acceptance, as dem-
onstrated by ablation studies in vivo (14). Anti-CD4 treatment 
resulted in prolonged survival of male skin grafts (Figure  4A) 
with some treated mice maintaining healthy grafts 10 weeks after 
treatment. In these mice, Foxp3+ cells could be detected in the 
draining lymph nodes (Figure 4B), non-draining lymph nodes, 
and spleen (data not shown). Even those mice that eventually 
rejected male grafts despite antibody treatment showed a similar 
frequency of Foxp3+ cells in secondary lymphoid organs. This 
could imply that, even despite eventual rejection, there had been 
a sufficient duration of antigen exposure to stabilize some pTreg. 
By contrast, Foxp3+ cells remained undetectable in mice treated 
with antibody and a female graft, and, as expected, in mice treated 
with antibody alone. These data indicate that antigen is needed 
for in vivo induction and does not exclude a role for antigen in the 
long-term stabilization of Foxp3 expression.
Cells from anti-CD4 treated mice receiving a male skin 
graft were pooled and analyzed for the hallmark Treg-specific 
hypomethylation pattern (Figure  4C). Foxp3+ cells isolated 
from mice that tolerated their graft demonstrated an nTreg-
Me methylation status comparable to control naive Treg from 
B6.Foxp3hCD2 reporter mice. Of note, anti-CD4 treated mice that 
rejected their grafts also displayed full demethylation of the TSDR 
region, suggesting that they too developed pTreg that are epige-
netically indistinguishable from nTreg (Figure 4C; Figure S3 in 
Supplementary Material). Thus, despite the observed induction 
FigUre 4 | antigen exposure in combination with coreceptor blockade generates pTreg with Treg-specific hypomethylation that delay graft 
rejection. (a) Female B6.RAG1−/− Marilyn.Foxp3hCD2 mice were injected intra-peritoneally with 1 mg anti-CD4 (YTS 177.9) at days 0, 3, and 5 and grafted with either 
male (n = 17) or female (n = 4) B6.RAG1−/− donor skin. Control mice received male B6.RAG1−/− skin without antibody treatment. Statistical analysis Log-Rank test; 
p < 0.001 for male graft with versus without αCD4 treatment. (B) Analysis of Foxp3 expression in draining lymph nodes of treated mice. Data are representative of 
replicates for mice receiving no male grafts, including two mice receiving anti-CD4 treatment only and four mice receiving female grafts given under cover of 
anti-CD4. Four mice also received male grafts without anti-CD4 antibody treatment. Plots for anti-CD4 treated mice maintaining (n = 3) or rejecting (n = 3) male 
grafts represent pooled data. Similar results were obtained for non-draining lymph nodes and spleen (data not shown). All cells were isolated 10 weeks after grafting. 
(c) Sorted cells were assessed for Treg-specific hypomethylation status of the TSDR locus and “nTreg-Me” loci (iTreg tolerant mice only). nTregs are shown for 
comparison. Foxp3− cells from rejecting mice demonstrate full TSDR methylation. All cells isolated from mice 10 weeks after grafting.
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of pTreg, male grafts, in this experiment, were eventually rejected 
in a large proportion of mice indicating that there were probably 
insufficient pTreg to prevent rejection by Foxp3− antigen-specific 
effector cells. As expected, those T  cells that remained Foxp3− 
after anti-CD4 treatment retained full methylation at the TSDR 
locus.
Collectively, these data indicate that coreceptor blockade given 
with the allograft, but not without it, enables induction of pTreg 
epigenetically similar to nTreg, and by inference, cells that are 
relatively stable, and exhibit limited plasticity. Our data indicate 
that this exposure to antigen at the outset, and presumably TCR 
signaling, is necessary to generate the epigenetically stable pTreg.
DiscUssiOn
In this report, we have shown for the first time that some periph-
erally induced and in vitro generated Treg are stable in the context 
of renewed exposure to cognate antigen and are epigenetically 
indistinguishable from nTreg at the Foxp3 TSDR and nTreg-Me. 
This is the first demonstration of the stability and epigenetic 
maturation of pure peripheral Treg in an allogeneic transplant 
setting.
Regulatory T cells expressing Foxp3 require hypomethylation 
at specific sites to ensure their functional stability over time. This 
hypomethylation pattern is the most reliable tool that we have 
7Hilbrands et al. Hypomethylation Patterns of iTreg in Tolerated Grafts
Frontiers in Immunology | www.frontiersin.org April 2016 | Volume 7 | Article 124
today to identify T cells committed to the Foxp3+ Treg lineage. 
Although some of the molecular mechanisms leading toward 
Foxp3+ Treg hypomethylation have been characterized for Treg 
developing in the thymus, they remain incompletely understood 
for peripherally-induced Treg, in  vivo, and have not yet been 
reported in the setting of transplantation. Functionally, forced 
demethylation of the TSDR by knocking down DNA methyl 
transferase 1 (Dnmt1) results in a stable Treg phenotype (5). 
We studied the acquisition of epigenetic changes both in TGF-
β-induced iTreg adoptively transferred into RAG−/− mice and in 
pTreg developing from naive CD4+ T cells in mice lacking any 
Treg. Our data demonstrate an essential role for antigen in both 
cell types for Treg maintenance. In the absence of sufficient Foxp3+ 
T-cells accumulating in mice not exposed to the allo-antigen, we 
cannot rule out any additional role for antigen in maintaining the 
hallmark epigenetic pattern of Treg.
In vitro-induced Foxp3+ Treg is a potential source of thera-
peutic cells for clinical applications but their stability remains 
uncertain since epigenetic changes are incomplete. Our data 
demonstrate that in vitro TGF-β-induced Foxp3+ Treg are unable 
to reject skin grafts and some cells continue to maintain their 
epigenetic changes, in vivo, resulting in a demethylated TSDR to 
the same extent as seen in nTreg. Our findings show an impor-
tant role for the renewed contact with antigen for epigenetically 
stable cells to accumulate. Previous work has suggested that, in 
the context of an ongoing autoimmune inflammatory response, 
autoreactive Treg become unstable over time (21). The inflam-
matory response to skin engraftment is insufficient in itself to 
promote pTreg induction or iTreg maintenance as evidenced 
by lack of pTreg induction and iTreg reduction in numbers in 
recipients of female grafts. This has precluded us from being 
able to analyze epigenetic changes in the very rare Foxp3+ 
T-cells that are detectable after such treatments. However, the 
transient inflammation observed in our model does not inhibit 
the emergence of pTreg or persistance of iTreg in the presence 
of cognate antigen. Whether antigen promotes survival or pro-
liferation of Treg cannot be concluded from our study. However, 
the fact that continuous TCR stimulation is able to induce a 
certain level of Treg-specific epigenetic changes in naive CD4+ 
T cells in vitro over the short term (5) indicates that they might 
need a longer period of antigen exposure for full maturation or 
stabilization in vivo. These persisting cells may have proliferated 
more efficiently in the presence of antigen explaining the higher 
numbers when compared with iTreg levels in mice lacking anti-
gen. Collectively, our data support a role for renewed antigen 
exposure for sustained suppression by iTreg after in vivo transfer, 
since no rejection occurred despite the presence of effector 
T cells capable of rejection.
Enhancing Foxp3+ Treg numbers within the body is an 
alternative strategy to promote tolerance that may be more 
applicable to clinical translation in the long term than paren-
teral cell infusion-based therapies. Our data demonstrate that 
in vivo-induced antigen-specific Foxp3+ Treg can acquire specific 
hypomethylation, and consequently, lineage commitment and 
optimal stability. In this model, no Foxp3+ tTreg were present at 
the beginning of the experiment, so any Treg emerging (pTreg) 
had done so de novo.
It is unknown whether TSDR and nTreg-Me demethylation 
precede or are consequent to Foxp3 gene transcription during 
coreceptor blockade induction of pTreg. Treg developing in the 
thymus have been shown to mature in a two-step fashion with 
epigenetic maturation starting at early stages of tTreg develop-
ment that complement Foxp3 expression to ensure stable Treg 
function. However, both processes occur independently of each 
other. Moreover, TCR stimulation is clearly required in the early 
development of nTreg-Me (5) but appears dispensable for the 
maintenance of the hypomethylation pattern in mature Treg 
cells (22). These findings suggest that other, yet unidentified 
factors are required to maintain and maybe also initiate the 
epigenetic landscape of Treg. Our data support the findings that 
TCR signaling is essential for the development and accumula-
tion of T-cells with the Treg-specific hypomethylation pattern 
and confirm that this can be achieved independently of thymic 
input. It is clear that continuous TCR signaling is required for 
activated Treg to exert adequate Treg function (19), and the 
conclusion is also being supported by our study. However, 
the degree to which TCR signaling is required for ensuring 
maintenance of the epigenetically mature state remains to be 
established for tTreg, iTreg, and pTreg. Either way strategies to 
enhance numbers of pTreg to tame inflammatory diseases may 
need to take account of a need for recurrent/persistent TCR 
signaling.
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FigUre s1 | lollipop diagram showing cpg methylation status per clone 
(8–13 independent clones for each region). Female mice demonstrate 
approximately 50% methylation of the TSDR locus in nTreg by X-chromosome 
inactivation. Spaces with no “lollipops” represent regions with ambiguous 
sequence data.
FigUre s2 | lollipop diagram showing cpg methylation  
status per clone (8–27 independent clones for each region) from  
iTreg pre-transfer and after retrieval in mice grafted with  
a male skin graft. Spaces with no “lollipops” represent regions with ambiguous 
sequence data.
FigUre s3 | lollipop diagram showing cpg methylation status per clone 
(9–18 independent clones for each region) from T cells retrieved 10 
weeks after treatment with a male skin graft and YTs177.9. Foxp3pos cells 
and Foxp3neg cells were analysed from mice where grafts were not rejected at 
week 10 (a) and mice where grafts we rejected (B). Spaces with no “lollipops” 
represent regions with ambiguous sequence data.
